Sentry Data Systems Is the Latest 340B TPA to Change Hands

“Sentry looks forward to continuing to innovate and grow with its new partnership with Craneware," Sentry CEO Travis Leonardi said about his company's sale this week.
Healthcare data analytics company Craneware is buying 340B third-party administrator Sentry Data Systems, the latest in a series of 340B TPA acquisitions.

Please Login or Become a Paid Subscriber to View this Content

Read More »

Health Centers Launch a New National Advocacy Group

Kerry Hydash (left) is Board Chair and Amanda Pears Kelly is Executive Director of the new health center group Advocates for Community Health.
Community health center leaders have created a new membership organization—Advocates for Community Health (ACH)—to influence federal health care policy and “drive a new vision for the role health centers can and should play in an evolving 21st century health care
Read More »

Tech Firm Convening Working Group to Address 340B Duplicate Discounts

Susanne Somerville, CEO of life sciences information sharing consulting firm Chronicled, thinks blockchain technology could be the solution to 340B duplicate discounts.
A Bay Area health care tech firm is convening a work group to try to solve the problem of duplicate 340B discounts and Medicaid rebates on the same drugs.

Please Login or Become a Paid Subscriber

Read More »

24 Health Systems List 8 Ways HHS Can Stabilize 340B Without Involving Congress

Ending the deep cut in 340B hospitals' Medicare drug reimbursement topped two dozen health systems' list of 340B recommendations for HHS Secretary Xavier Becerra. | C-SPAN
Twenty four large health systems with hospitals in the 340B program yesterday sent U.S. Health and Human Services (HHS) Secretary Xavier Becerra eight recommendations “to stabilize this program for the long-term” that he could implement without involving Congress.
Read More »

Express Scripts Defends 340B Claims ID Requirement

Express Scripts told 340B covered entities in recent letters that it has granted "numerous" extensions of time for pharmacies to comply with its new 340B claims identification process.
Pharmacy benefits manager Express Scripts (ESI) told a hospital group and an HIV/AIDS clinic in recent days that it has “already granted numerous pharmacies extensions” to its controversial new 340B claims identification requirement that went into effect March 1.
Read More »

340B Groups Ask Express Scripts to Drop Claims Submission and ID Requirement

The 340B Coalition told Express Scripts that covered entities cannot comply with its new 340B claims submission and identification requirement absent "a massive investment of financial and human resources." | Shutterstock
Groups representing 340B health care providers have asked pharmacy benefit manager Express Scripts (ESI) to stop making 340B providers and their contract pharmacies retrospectively submit and flag 340B claims in a way that has never been done before, and that
Read More »

Amazon Is Opening its Employees-only Primary and Urgent Care Service to Companies Nationwide

Amazon Care, the online retailer's expanded telehealth and home-visit health care service, includes “prescription delivery right to a patient’s door.” | Amazon
Online retailer Amazon announced yesterday that it began offering companies in Washington state access to its Amazon Care telehealth and home-visit primary and urgent health care services, which include “prescription delivery right to a patient’s door.”
Read More »

Opposition to Express Scripts’ 340B Claims ID Requirement Grows

U.S. Rep. Abigail Spanberger (D-Va.) has been in close contact with 340B covered entity organizations to explore the implications of Express Scripts’ actions on 340B covered entities, her office told 340B Report this afternoon.
Legislation addressing pharmacy benefit manager Express Scripts’ (ESI) new claims identification requirement for 340B drugs could be introduced in Congress soon, advisers to 340B covered entities said yesterday.

Please Login or Become a Paid Subscriber to

Read More »

Providers Worried About Humana’s 340B Claims ID and Data-Reporting Conditions

340B covered entities are worried that Humana may begin widespread rejection of claims for prescriptions filled with 340B drugs, and may begin auditing 340B claims more aggressively.
Health insurance company Humana has begun sending pharmacy provider agreements for 2022 to 340B-participating pharmacies, with claims-identification and data-reporting conditions that some 340B providers say are unsettling. They say the agreements are to be signed and returned within 30 days
Read More »

340B Report Publisher/CEO: Look for a Return to an Era of 340B Guidance

Recent developments in federal court bode well for 340B providers trying to restore access to 340B pricing in the contract pharmacy setting, 340B Report Publisher and CEO Ted Slafsky’s take in his latest column for the Omnicell blog
The Biden administration’s embrace of the federal government’s traditional stance on the enforceability of program guidance—which the Trump administration rejected—may lead to stronger enforcement of 340B program guidance and possibly even the issuance of new 340B guidelines, 340B Report Publisher
Read More »